Teams
Imagine's Offers
-
Mapple Syrup Urine Diseases
Mapple Syrup Urine DiseasesGenotype PhenotypeTargetsTherapeuticsClinical trialsOther intoxication type disorders
PKUGenotype PhenotypeTargetsTherapeuticsClinical trialsTyrosinemia type 1Genotype PhenotypeTargetsTherapeuticsClinical trialsUrea cycle disordersGenotype PhenotypeTargetsTherapeuticsClinical trialsOrganic acidurias (MMA, PA and IVA)Genotype PhenotypeTargetsTherapeuticsClinical trialsInborn errors of homocysteine metabolismGenotype PhenotypeTargetsTherapeuticsClinical trials -
Mitochondrial disorders
See Mitochondrial disorders
Other disorders of energy metabolism
Lipin-1 deficiency rhabdomyolysisGenotype PhenotypeTargetsTherapeuticsClinical trialsHyperinsulinemic hypoglycemiaGenotype PhenotypeTargetsTherapeuticsClinical trialsMitochondrial fatty oxidation disordersGenotype PhenotypeTargetsTherapeuticsClinical trialsGlycogen Storage DiseasesGenotype PhenotypeTargetsTherapeuticsClinical trials -
Lysosomal storage disorders
Muccopolysaccharidoses type 1 to 7Genotype PhenotypeTargetsTherapeuticsClinical trialsPompe diseaseGenotype PhenotypeTargetsTherapeuticsClinical trialsWolman diseaseGenotype PhenotypeTargetsTherapeuticsClinical trialsGaucher diseaseGenotype PhenotypeTargetsTherapeuticsClinical trialsCongenital disorders of glycosylation
Congenital disorders of glycosylationGenotype PhenotypeTargetsTherapeuticsClinical trials -
Neurometabolic diseasesGenotype PhenotypeTargetsTherapeuticsClinical trialsNeurotransmitter disordersGenotype PhenotypeTargetsTherapeuticsClinical trials
Contacts
-
Marion Pilorge
Business development manager
- +33 1 42 75 45 65
-
Thibaut PERCHET
Business development manager
- thibaut.perchet@institutimagine.org
- +33 1 42 75 42 55